Literature DB >> 10383390

All-trans-retinoic acid-mediated growth inhibition involves inhibition of human kinesin-related protein HsEg5.

A Kaiser1, F H Brembeck, B Nicke, B Wiedenmann, E O Riecken, S Rosewicz.   

Abstract

In this study we used differential display reverse transcription-polymerase chain reaction to search for differentially expressed all-trans-retinoic acid (ATRA)-responsive genes in pancreatic carcinoma cells. We identified the kinesin-related protein HsEg5, which plays an essential role in spindle assembly and spindle function during mitosis, as a novel molecule involved in ATRA-mediated growth inhibition. Using Northern and Western blot analysis we demonstrated that ATRA significantly inhibits HsEg5 expression in various pancreatic carcinoma cell lines as well as in HaCat keratinocytes. Inhibition of HsEg5 expression by ATRA occurs at the posttranscriptional level. As a consequence, tumor cells synchronized in S-phase revealed a retarded progression through G2/M phase of the cell cycle indicating that HsEg5 inhibition results in a delayed progression through mitosis. Furthermore, a significant decrease of HsEg5 protein expression achieved by antisense transfection revealed a significant growth inhibition compared with control cells. Therefore, HsEg5 represents a novel molecule involved in ATRA-mediated growth inhibition, suggesting that vitamin A derivatives can interact with the bipolar spindle apparatus during mitosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10383390     DOI: 10.1074/jbc.274.27.18925

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  Dimeric Eg5 maintains processivity through alternating-site catalysis with rate-limiting ATP hydrolysis.

Authors:  Troy C Krzysiak; Susan P Gilbert
Journal:  J Biol Chem       Date:  2006-10-23       Impact factor: 5.157

2.  Inhibition of KSP by ARRY-520 induces cell cycle block and cell death via the mitochondrial pathway in AML cells.

Authors:  B Z Carter; D H Mak; R Woessner; S Gross; W D Schober; Z Estrov; H Kantarjian; M Andreeff
Journal:  Leukemia       Date:  2009-05-21       Impact factor: 11.528

3.  Cancer drug therapy and stochastic modeling of "nano-motors".

Authors:  Lubna Sherin; Shabieh Farwa; Ayesha Sohail; Zhiwu Li; O Anwar Bég
Journal:  Int J Nanomedicine       Date:  2018-10-15

4.  High Eg5 expression predicts poor prognosis in breast cancer.

Authors:  Qin Jin; Fang Huang; Xudong Wang; Huijun Zhu; Yun Xian; Jieying Li; Shu Zhang; Qichao Ni
Journal:  Oncotarget       Date:  2017-07-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.